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Apolipoprotein E (apoE) is one of the amyloid associated
proteins that is found in the amyloid plaque of
Alzheimer’s disease and systemic amyloidosis. ApoE
might play an important part in the etiology of
Alzheimer’s disease by functioning as a ‘‘pathologic
chaperone’’ to promote the formation of amyloid fila-
ments. In this study, we investigated whether apoE is
associated with amyloid deposits of primary localized
cutaneous amyloidosis using immunohistochemistry,
immunogold electron microscopy, and immunoblotting.
The subjects consisted of 12 patients with lichen
amyloidosus and one patient with macular amyloidosis.
Light microscopically, amyloid deposits in the dermal
papillae were round in shape and stained with Congo red.
Immunohistochemically, apoE was detected in amyloid
Apolipoprotein E (apoE) is a protein of molecular weightof 34,200 (299 amino acid residues) and is a componentof lipoproteins of VLDL, IDL, HDL, and chylomicron.ApoE interacts with the ‘‘remnant receptor’’ (apoEreceptor) and the low-density lipoprotein (LDL) recep-
tors (apoE/B receptor) of the liver and other organs to modulate the
catabolism of triglyceride-rich lipoprotein particles (Poirier et al, 1993).
The protein is also produced and secreted in the skin, and implicated
to play roles in epidermal differentiation and proliferation (Barra et al,
1994). Localization of apoE in the normal skin has been demonstrated
by immunohistochemistry (Miyauchi, 1991), and the relationship
between the apoE allele and a skin disease has been shown (Furumoto
et al, 1997). It has been reported that apoE is associated with the
amyloid plaque of various amyloid-forming diseases (e.g., Alzheimer’s
disease, Creutzfeldt–Jakob disease, and Down’s syndrome) (Namba
et al, 1991). ApoE is found both in senile plaques and in amyloid
deposits in the cerebral vessel associated with Alzheimer’s disease
(Namba et al, 1991; Wisniewski and Frangione, 1992; Strittmatter et al,
1993a). Although the biochemical function of apoE in amyloid
has not been clarified, apoE may be related to the formation of
amyloid fibrils.
Primary localized cutaneous amyloidosis (PLCA), lichen amyloido-
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deposits in all the cases examined. Immunogold electron
microscopy showed apoE immunoreactivity on the
amyloid deposition. Immunoblots of amyloid-positive
skin showed 35K and 14K proteins, which were taken to
be apoE and its fragment, respectively. In normal skin
extract, only the 35K protein was detected by the anti-
human apoE. Moreover, the intensity of the amyloid-
positive skin sample was stronger than that of the normal
skin sample. Monoclonal anti-cytokeratin antibody
reacted with the 45K protein of the amyloid-positive skin
extract. These results indicate that apoE is a component
of primary localized cutaneous amyloidosis, and that
it might play an important role in primary localized
cutaneous amyloidosis. Key words: immunoblotting/
immunogold electron microscopy/immunohistochemistry. J Invest
Dermatol 111:417–421, 1998
sus, and macular amyloidosis are characterized by the finding that the
amyloid deposits are limited to the papillary dermis (Kumakiri and
Hashimoto, 1979 ). There is a hypothesis that the precursor protein
of PLCA might be keratin protein from epidermal keratinocytes
(Hashimoto et al, 1990). The pathogenesis of PLCA, however, remains
undetermined and the amyloid fibril protein has not been identified.
Recently, Yamada et al (1994) reported that fragments of apoE were
common constituents of amyloid fibrils in systemic amyloidosis, but
there have been no reports on the relationship between apoE and
PLCA. The aim of this study was to clarify the relationship between
apoE and amyloid in PLCA using immunohistochemistry, electron
microscopy, and immunoblotting. We also discuss the role of apoE in
the formation of amyloid in PLCA.
MATERIALS AND METHODS
Immunohistochemistry
Tissue specimens Skin biopsies were obtained from 12 patients with lichen
amyloidosus and one patient with macular amyloidosis (Table I). In the patients
with lichen amyloidosus, the lesions were located on the legs or the back. In
the patient with macular amyloidosis, the hyperpigmented lesion on the back
was examined. Formalin-fixed, paraffin-embedded blocks were cut in 4 µm
thick sections. The presence of amyloid was confirmed by staining serial sections
with Congo red and demonstrating birefringence in polarized light. For the
control specimens of immunohistochemical staining, histologically normal skins
were investigated using anti-apoE antibody.
Immunoperoxidase staining Sections were deparaffinized in xylene and washed
in 50 mM Tris-buffered saline (pH 7.6). Endogenous peroxidase activity was
destroyed by incubating with 3% hydrogen peroxide in methanol at room
temperature for 10 min, and the sections were incubated in normal swine
serum (DAKO PAP, DAKO, Copenhagen, Denmark) for 30 min to reduce
non-specific background staining. The sections were incubated in moist
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Table I. Clinical data and immunohistochemical findings of
primary localized cutaneous amyloidosis
Type of Agec Reactivity to anti-human
No. amyloidosisa Sexb (y) apoE antibody
1 LA M 47 1
2 LA M 82 1
3 LA F 67 1
4 LA F 73 1
5 LA M 40 1
6 LA M 57 1
7 LA M 67 1
8 LA F 26 1
9 LA M 57 1
10 LA M 41 1
11 LA M 65 1
12 LA F 71 1
13 MA F 84 1
Total 13/13 (100%)
a LA, lichen amyloidosus; MA, macular amyloidosis.
b M, male; F, female.
c Age at skin biopsy.
chambers with polyclonal rabbit anti-human apoE antibody (DAKO) diluted
1:50 at 37°C for 30 min and followed by incubating with swine immunoglobulins
to rabbit immunoglobulins (DAKO) for 30 min. They were incubated with
peroxidase rabbit anti-peroxidase complexes (DAKO) for 30 min. They were
then incubated with 39,39-deamino-benzidine tetrahydrochloride in H2O2 for
5 min, followed by hematoxylin staining.
Electron microscopic immunocytochemistry
Tissue processing A case of lichen amyloidosus was examined. The biopsy was
taken from the hyperpigmented papules on the back. The tissues were
immediately cut into small pieces about 1 mm3 and were fixed in 2%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). After an overnight rinse
with 0.1 M cacodylate buffer, they were dehydrated in alcohol and embedded
in Epon 812 for the immunogold electron microscopy. For conventional
electron microscopy, they were postfixed in 1% osmium tetroxide for 1 h,
dehydrated, and embedded in Epon 812.
Post-embedding colloidal gold labeling Thin sections were cut and
collected on 150-mesh nickel grids coated with 2% Collodion solution in amyl
acetate (Ohken, Tokyo, Japan) for improved section adhesion. Post-embedding
immunocytochemistry was performed by techniques previously described
(Phend et al, 1995; Takahashi et al, 1996). Briefly, grids were washed with
10 mM phosphate-buffered saline (PBS, pH 7.4) for 30 min. Then binding of
non-specific antibodies was blocked with PBS containing 1% bovine serum
albumin for an hour. The sections were incubated with rabbit anti-human apoE
antibody (DAKO) diluted (1:200) with PBS containing 1% bovine serum
albumin overnight. After several rinses with PBS, the sections were treated
with PBS containing 1% bovine serum albumin for 1 h to block non-specific
binding sites. The sections were then incubated with anti-rabbit IgG conjugated
20 nm colloidal gold particles (EY Laboratories, San Mateo, CA) diluted (1:10)
with PBS containing 1% bovine serum albumin for 4 h. They were then
washed with PBS three times and with distilled water (DW), and stained with
uranyl acetate and lead citrate solution. Sections were examined in an H-800
electron microscope (Hitachi, Tokyo, Japan).
Extraction of amyloid proteins Amyloid-positive skin biopsy was obtained
from a patient with lichen amyloidosus. Amyloid proteins were extracted
according to the procedures of Kaplan et al (1993). Briefly, the sample of
amyloid-containing tissue was dispersed in saline and incubated overnight at
room temperature with a moderate shaking. The sample was centrifuged at
14,000 r.p.m. for 10 min. The supernatant was discarded, the pellet was
redispersed in saline and centrifuged, and this procedure was repeated four
times. The pellet was then washed with DW and homogenized in aqueous
20% acetonitrile solution containing 0.1% trifluoroacetic acid. The homogenate
was incubated at room temperature for several hours with a moderate shaking
and centrifuged for 10 min at 14,000 r.p.m. The supernatant was pooled and
lyophilized. The pellet was redispersed in 20% acetonitrile solution containing
0.1% trifluoroacetic acid and the procedure was repeated four times. For the
control, histologically normal skins were investigated for extraction of insoluble
fractions and immunoblotting.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
immunoblotting of amyloid protein The samples were dissolved in
62.5 mM Tris-HCl pH 6.8 sample buffer containing 3% sodium dodecyl sulfate,
10% 2-mercaptoethanol, and 20% glycerol. The samples of amyloid proteins
were analyzed by sodium dodecyl sulfate-polyacrylamide gel (15%T and
2.67%C) electrophoresis as described by Laemmli (1970). The proteins were
electrotransfered from the gel to a polyvinylidene difluoride membrane
(Immobilon, Millipore, Japan) using 3-[cyclohexylamino]-1-propanesulfonic
acid (Sigma, St. Louis, MO) in methanol pH 11 (Matsudaira, 1987). The
polyvinylidene difluoride membrane was stained with Coomassie Brilliant
Blue R-250. Immunostaining was performed using a goat anti-human apoE
(Phenotyping ApoE IEF system, Joko, Tokyo, Japan) at a dilution of 1:500 as
the first antibody and alkaline phosphatase conjugated rabbit anti-goat IgG
(Phenotyping ApoE IEF system, Joko) at a dilution of 1:500 as the second
antibody, according to the procedure described by Blake et al (1984). In a
further experiment, cytokeratins were also identified by a murine monoclonal
anti-cytokeratin antibody (MNF-116 clone, DAKO) at a dilution of 1:500,
followed by horse radish peroxidase-conjugated goat anti-mouse immuno-
globulins (Cappel, Costa Mesa, CA) at a dilution of 1:500. The peroxidase
reaction product was visualized using 4-chloro naphthol (Sakurai et al, 1986).
For the positive controls of immunostaining, normal human serum and purified
human keratin (Sigma) were investigated using anti-apoE antibody and anti-
cytokeratin antibody, respectively. In principle, cytokeratin and intermediate
filaments can be solubilized in high concentrations (9–10 M) of urea (Achtstaetter
et al, 1986). The skin extracts were also solubilized in the buffer containing
9.5 M urea, 5% Nonidet P-40, and 5% 2-mercaptoethanol at room temperature
for 30 min, to which equal volumes of the sample buffer were added. The
protein solutions were then subjected to the immunoblotting. The samples
loaded on the focusing gel were prepared in the same quantity of protein.
RESULTS
Amyloid deposits in PLCA react with anti-apoE Amyloid was
detected in the lesions of all cases. Light microscopically, the deposits
were small in size and were weakly eosinophilic materials in the dermal
papillae on hematoxylin and eosin-stained preparations. The deposits
were stained with Congo-red and showed emerald-green birefringence
under polarized light. Most of the congophilic amorphous masses were
in the form of nodules measuring about 10–30 µm in diameter (Fig 1A).
Rabbit anti-apoE antibody reacted with epidermal cells, particularly
basal cells, and strongly reacted with sebaceous glands. ApoE-immuno-
reactive amyloid deposits were detected in the dermis of sections from
all the cases examined (Table I, Fig 1B). The staining intensity of
apoE was varied in each section, but the interstitium of the dermis
showed negative staining with apoE.
Amyloid fibrils are observed in the papilla and reticular dermis
using electron microscopy At low magnification, amyloid deposits
were found as electron-dense round or oval individual islands. Amyloid
deposits exhibited a nodular or granular form beneath the basement
membrane or among the collagen fibers in the dermis (Fig 2A). At
higher magnification, amyloid fibrils were seen as irregular string-like
structures of varying thickness and density along their length, measuring
7–10 nm in width. Morphologic changes of the dermo–epidermal
junction were seen near the amyloid deposits. Some regions of basal
lamina were destroyed and could not keep the structure. There was
no amyloid deposit in the reticular dermis and the perivascular area.
Amyloid deposits are labeled with 20 nm gold particles to anti-
apoE antibody After immunolabeling for apoE, amyloid deposits
were positively labeled with 20 nm gold particles (Fig 2B). Collagen
fibers were not labeled with the gold particles.
ApoE and cytokeratin are present in the skin extracts
Immunoblots of amyloid-positive skin showed 35K and 14K protein
bands that were reacted with anti-apoE antibody (Fig 3A). The 35K
and 14K proteins were considered to be apoE and its fragment,
respectively (Yamada et al, 1994). In normal skin extract, only 35K
protein was detected by the anti-human apoE. The intensity of the
35K protein band of the amyloid-positive sample was stronger than
that of the normal skin sample (Fig 3A). The difference in the intensity
of immunostaining paralleled the amount of protein. The 45K protein
band was detected by the anti-cytokeratin antibody in an amyloid-
positive case, but not in a normal case. In the skin samples solubilized
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Figure 1. Lichen amyloidosus stained with Congo red (A) and anti-
apoE serum (B). Congo red-positive amyloid deposits, indicated by arrows,
react with anti-apoE anti-serum. Scale bars: 100 µm.
with 9.5 M of urea, the antibody reacted with higher molecular weight
bands of cytokeratin, 54K in the amyloid positive case and 67K in the
normal case (Fig 3B).
DISCUSSION
In this study we demonstrated the presence of apoE in PLCA by three
methods, immunohistochemistry, immunoelectron microscopy, and
immunoblotting. In amyloid-positive skin extract, immunoblotting
using polyclonal anti-apoE antibody demonstrated the existence of
35K and 14K proteins that were regarded as apoE and its fragment.
The 35K protein band of normal skin sample is considered to be apoE
naturally synthesized by the epidermal keratinocytes, and the intensity
of the band was weaker than that of the amyloid-positive skin sample.
In systemic amyloidosis, the small molecular weight (14K and 7K)
bands, which corresponded to fragmented peptides of apoE, were
detected by immunoblotting of AA fibril using monoclonal anti-apoE
antibody (Yamada et al, 1994). The 14K band was detected in both
PLCA and systemic amyloidosis but not in normal skin. The 14K
fragmented peptide of apoE might play an important role in the
pathogenesis of PLCA.
It has been suggested that, in immunogold electron microscopic
preparations, the relevant antigenicity for trapped plasma protein is
neither preserved by the tissue processing nor revealed by the etching
procedure (Donini et al, 1989). Moreover, in the course of extraction
of amyloid proteins, trapped plasma proteins were washed out during
incubations in saline. Thus, it seems reasonable to assume that apoE
and its product, which were detected in PLCA, were components of
the amyloid.
Figure 2. Electron microscopic findings of lichen amyloidosus. (A) At
low magnification of conventional electron microscopy, amyloid deposits
show nodular electron-dense individual islands in the upper dermis. (B) By
postembedding immunogold electron microscopic procedure, 20 nm gold
particles to anti-apoE anti-serurn label on amyloid deposits. Scale bar: (A) 3 µm;
(B) 0.2 µm.
ApoE is one of the amyloid-associated proteins that might play a
key role in the etiology of Alzheimer’s disease by functioning as a
‘‘pathologic chaperone’’ to promote the formation of amyloid filaments
(Wisniewski and Frangione, 1992). Recent studies have implicated
that apoE plays a role in the accumulation of proteins in the senile
plaques and congophilic angiopathy of Alzheimer’s disease (Strittmatter
et al, 1993b). ApoE is also associated with all cerebral and systemic
amyloids, apparently reflecting a more general affinity for the β-pleated
sheet conformation characteristic of amyloid filaments (Ma et al, 1994);
however, there have been no reports on the relationship between apoE
and PLCA.
PLCA, lichen amyloidosus, or macular amyloidosis are characterized
by the findings that the amyloid deposits are limited exclusively to the
papillary dermis (Kumakiri et al, 1979). Hashimoto et al (1990) proposed
the term amyloid-k disease for the skin-limited amyloidosis derived
from keratin protein. In most skin-limited amyloidoses, ‘‘amyloid
deposits’’ have been found using immunohistochemical techniques to
contain keratin proteins or their derivatives. Some monoclonal anti-
keratin antibodies reacted with amyloid deposits of the PLCA (Yoneda
et al, 1989; Hashimoto et al, 1990). It is suggested that the amyloid
substances come from a special degeneration of keratinocytes of
the epidermis. In this study, immunoblots of amyloid extract using
monoclonal anti-cytokeratin antibody showed the 45K protein band.
Using the buffer containing 9.5 M urea, the anti-cytokeratin antibody
reacted with 67K and 54K protein in the normal skin and amyloid-
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Figure 3. Separation of apoE and cytokeratin in skin extracts by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and immuno-
blotting. (A) Immunostaining using goat anti-human apoE antibody; (B)
immunostaining using murine anti-cytokeratin antibody; (C) protein staining
with Coomassie blue R-250. Lane 1, molecular weight standards; lane 2, normal
human serum; lane 3, human keratin; lane 4, extracts of amyloid-positive skin;
lane 5, extracts of normal skin; lane 6, extracts of amyloid-positive skin solubilized
in buffer containing 9.5 M of urea; lane 7, extracts of normal skin solubilized
in buffer containing 9.5 M of urea.
positive skin, respectively. Although the 45K and 54K proteins might
be associated with amyloid deposits of PLCA, the significance for the
formation of amyloid deposits in PLCA is uncertain.
In addition to the primary structure of amyloid precursor proteins,
other elements, which confer a susceptibility to amyloid formation,
may be important for the initiation, development, and persistence of
amyloid deposits: proteoglycans, glycosaminoglycans (GAG), amyloid
P component, apoE, vitronectin, and so on, most of which are normal
constituents of basement membrane (Bellotti and Merlini, 1996;
Dahlba¨ck et al, 1998). In order to clarify the role of apoE in the
formation of amyloid deposits in PLCA, we have to investigate the
binding of apoE to isolated keratin filaments as previously shown for
serum amyloid P component and vitronectin (Hintner et al, 1988, 1989).
ApoE is synthesized by many organs, including the skin, and secreted
into systemic circulation (Fenjves et al, 1989, 1994). ApoE in the
amyloid deposits in PLCA might be derived from the epidermal
keratinocytes. The localization of apoE in the normal skin has been
revealed by immunohistochemical methods (Miyauchi, 1991). ApoE
is observed intracellularly and also in the basement membrane of the
dermo–epidermal junction. In vitro, apoE is secreted by basal cells in
the culture of epidermal keratinocytes (Gordon et al, 1989; Barra et al,
1994). Moreover, in the animal model, apoE is physiologically secreted
by epidermal keratinocytes and enters into systemic circulation (Fenjves
et al, 1989, 1994). Thus, apoE secreted by the epidermal keratinocytes
may play a part in the formation of amyloid filaments in the papillary
dermis. Another amyloid-associated matrix protein, GAG, which is a
constituent of almost all types of amyloid deposits, is also synthesized
by the epidermal keratinocytes and is a composition of the basement
membrane of the dermo–epidermal junction (Snow et al, 1987). There
have been no reports on the localization of GAG in PLCA. In our
cases, amyloid deposits were positively stained with sulfate alcian blue
(data not shown), indicating the existence of GAG. ApoE has binding
capacities to heparin sulfate (Mahley, 1988), which is thought to be a
predominant composition of GAG in amyloid deposits (Norling et al,
1988). These data lead to a hypothesis that degenerating apoE, derived
from apoptotic keratinocytes or basement membrane, may present in
the amyloid deposits of PLCA in conjunction with other amyloid
associated matrix proteins such as GAG.
ApoE is a polymorphic protein, and has the biologic functions
related to the lipid metabolism. Three common alleles for apoE have
been designated as ε4, ε3, and ε2, and their gene products are E4, E3,
and E2, respectively. Amino acid sequence analysis established that the
two common variants of apoE, E4 and E2, differ from E3 by a single
amino acid substitution. In E4, arginine is substituted for cysteine at
residue 112, and in E2 cysteine for arginine at residue 158. The
relationship between apoE2 and type III hyperlipoproteinemia has been
reported (Mahley, 1988). Recently we have reported the association of
apoE2 allele with psoriasis vulgaris in a Japanese population (Furumoto
et al, 1997). On the other hand, apoE4 allele is genetically linked to
the incidence of Alzheimer’s disease (Poirier et al, 1993; Martinoli et al,
1995), and the amount of β-amyloid deposition in senile plaques and
in the microvasculature of the patients with late-onset Alzheimer’s
disease, correlates with the E4 allele (Strittmatter et al, 1993a). Interest-
ingly, apoE2 inhibits the onset of late-onset Alzheimer’s disease (Corder
et al, 1994). Further study will be required to document the phenotypic
variation of apoE in cutaneous amyloidoses, including PLCA.
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